BPC-157 is a compounded peptide that is not FDA-approved for the indications described and is not marketed to treat, cure, prevent, or diagnose any disease
BPC-157 also increases the expression of growth hormone receptor in tendon fibroblasts at both the mRNA and protein levels
This synthetic research peptide is supplied in capsule form, with 60 capsules per container, each capsule containing 250 mcg of material
Ongoing oxidative stress is linked to many chronic diseases (1) including cancer, cardiovascular disease, diabetes, osteoarthritis, and dementia
For people interested in ALA, the key question is whether it fits their health history, medications, and current care plan